Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2022
has subject area
- 1101 Medical Biochemistry and Metabolomics (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Heart Failure (MeSH)
- Humans (MeSH)
- Hypoglycemic Agents (MeSH)
- Sodium-Glucose Transporter 2 Inhibitors (MeSH)